Cargando…

Impacts of the Quinazoline-Based Alpha1-Antagonist, Terazosin, and of the Sulfonamide Derivative, Tamsulosin, on Serum Prostate-Specific Antigen and Prostate Volume

The aim of this study was to compare the impacts of terazosin and tamsulosin, on prostate activity, i.e., serum prostate-specific antigen, total prostate volume (TPV), and transition zone volume (TZV). A total of 90 patients who presented with lower urinary tract symptoms (LUTS) secondary to benign...

Descripción completa

Detalles Bibliográficos
Autores principales:	Paick, Jae-Seung, Cho, Min Chul, Song, Sang Hoon, Kim, Soo Woong, Ku, Ja Hyeon
Formato:	Texto
Lenguaje:	English
Publicado:	The Korean Academy of Medical Sciences 2008
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2526511/ https://www.ncbi.nlm.nih.gov/pubmed/18583890 http://dx.doi.org/10.3346/jkms.2008.23.3.509

Ejemplares similares

Cost-Effectiveness of Tamsulosin, Doxazosin, and Terazosin in the Treatment of Benign Prostatic Hyperplasia
por: Ohsfeldt, Robert L., et al.
Publicado: (2004)

The effectiveness of tamsulosin hydrochloride with terazosin combination therapy for chronic prostatitis Type-III b
por: Duan, Bin, et al.
Publicado: (2022)

Comparison of relaxation responses of cavernous and trigonal smooth muscles from rabbits by alpha1-adrenoceptor antagonists; prazosin, terazosin, doxazosin, and tamsulosin.
por: Seo, K. K., et al.
Publicado: (1999)

Impact of Prostate Volume on the Efficacy of High-Power Potassium-Titanyl-Phosphate Photoselective Vaporization of the Prostate: A Retrospective, Short-Term Follow-Up Study on Evaluating Feasibility and Safety
por: Ku, Ja Hyeon, et al.
Publicado: (2010)

Changes in Nocturia after Photoselective Vaporization of the Prostate for Patients with Benign Prostatic Hyperplasia
por: Lee, Chang Ju, et al.
Publicado: (2010)

The Efficacy and Safety of Photoselective Vaporization of the Prostate with a Potassium-titanyl-phosphate Laser for Symptomatic Benign Prostatic Hyperplasia according to Prostate Size: 2-Year Surgical Outcomes
por: Kim, Hyung Suk, et al.
Publicado: (2010)

Terazosin Treatment Induces Caspase-3 Expression in the Rat Ventral Prostate
por: Papadopoulos, Georgios, et al.
Publicado: (2013)

The One Year Outcome after KTP Laser Vaporization of the Prostate According to the Calculated Vaporized Volume
por: Ku, Ja Hyeon, et al.
Publicado: (2009)

Patterns in the Diagnosis and Management of Benign Prostatic Hyperplasia in a Country that does not have Country-Specific Clinical Practice Guidelines
por: Paick, Jae-Seung, et al.
Publicado: (2007)

Effects of Tamsulosin on Premature Ejaculation in Men with Benign Prostatic Hyperplasia
por: Choi, Jae Hwi, et al.
Publicado: (2014)

Natural history of incidentally diagnosed prostate cancer after holmium laser enucleation of the prostate
por: Han, Jang Hee, et al.
Publicado: (2023)

High-Dose Terazosin Therapy (5 mg) in Korean Patients with Lower Urinary Tract Symptoms with or without Concomitant Hypertension: A Prospective, Open-Label Study
por: Kwak, Cheol, et al.
Publicado: (2007)

Intraoperative floppy iris syndrome associated with terazosin
por: Venkatesh, Rengaraj, et al.
Publicado: (2007)

Relationship of Postoperative Recatheterization and Intraoperative Bladder Distention Volume in Holmium Laser Enucleation of the Prostate for Benign Prostatic Hyperplasia
por: Kim, Hyeon Jun, et al.
Publicado: (2013)

Self-assessed goal achievement (SAGA) after Holmium laser enucleation of the prostate (HoLEP): Association with patients' postoperative satisfaction
por: Cho, Min Chul, et al.
Publicado: (2018)

Combination therapy with dutasteride and tamsulosin for the treatment of symptomatic enlarged prostate
por: Miller, J, et al.
Publicado: (2009)

Non-Invasive Predictors of Response to Tamsulosin for Benign Prostatic Obstruction
por: Shoaib, Mohammad, et al.
Publicado: (2021)

Design, Synthesis and Anticancer Evaluation of Novel Quinazoline-Sulfonamide Hybrids
por: Ghorab, Mostafa M., et al.
Publicado: (2016)

Terazosin Stimulates Pgk1 to Remedy Gastrointestinal Disorders
por: Liu, Jingjing, et al.
Publicado: (2021)

Role of Prostate Volume in the Early Detection of Prostate Cancer in a Cohort with Slowly Increasing Prostate Specific Antigen
por: Kim, Young Min, et al.
Publicado: (2013)

Meta-analysis of the efficacy and safety of combination of tamsulosin plus dutasteride compared with tamsulosin monotherapy in treating benign prostatic hyperplasia
por: Zhou, Zhongbao, et al.
Publicado: (2019)

Tamsulosin and Solifenacin in the Treatment of Benign Prostatic Hyperplasia in combination with overactive bladder
por: Wang, Hui, et al.
Publicado: (2017)

Evaluation of intermittent tamsulosin in treating symptomatic patients with benign prostatic hyperplasia
por: Soliman, Mohamed G., et al.
Publicado: (2023)

Relation of baseline prostate volume to improvement of lower urinary tract symptoms due to tamsulosin monotherapy in benign prostatic hyperplasia: An exploratory, multicenter, prospective study
por: El-Adawy, Mahmoud Shoukry, et al.
Publicado: (2020)

Association of Diet With Prostate Specific Antigen and Prostate Volume
por: Shirazi, Mehdi, et al.
Publicado: (2014)

Accuracy of a High Prostate-Specific Antigen Level for Prostate Cancer Diagnosis upon Initial Biopsy in Korean Men
por: Shim, Hong Bang, et al.
Publicado: (2007)

The Effect of Tamsulosin, Dutasteride Monotherapy and Tamsulosin-Dutasteride Combination on Prostate Smooth Muscle Contractility in BPH Model Wistar Strain Rattus Novergicus
por: Daryanto, Besut, et al.
Publicado: (2023)

Efficacy and tolerability of Roystonea regia lipid extract (D-004) and terazosin in men with symptomatic benign prostatic hyperplasia: a 6-month study
por: Guzmán, Raúl, et al.
Publicado: (2019)

The Effect of Tamsulosin, an Alpha-1 Receptor Antagonist as a Medical Expelling Agent in Success Rate of Ureteroscopic Lithotripsy
por: Ketabchi, Ali Asghar, et al.
Publicado: (2013)

Tamsulosin oral controlled absorption system (OCAS) in the treatment of benign prostatic hypertrophy
por: Neill, Mischel G, et al.
Publicado: (2008)

Efficacy of combination therapy with tamsulosin and zolpidem on nocturia in patients with benign prostatic hyperplasia
por: Miwa, Kousei, et al.
Publicado: (2011)

Transdermal iontophoresis delivery system for terazosin hydrochloride: an in vitro and in vivo study
por: Jiang, Changzhao, et al.
Publicado: (2021)

Free Prostate-Specific Antigen Provides More Precise Data on Benign Prostate Volume Than Total Prostate-Specific Antigen in Korean Population
por: Choi, Hoon, et al.
Publicado: (2013)

Efficacy and Tolerability of Tamsulosin 0.4 mg in Patients with Symptomatic Benign Prostatic Hyperplasia
por: Chung, Jae-Wook, et al.
Publicado: (2011)

Evaluation of silodosin in comparison to tamsulosin in benign prostatic hyperplasia: A randomized controlled trial
por: Pande, Satabdi, et al.
Publicado: (2014)

A comparison of the efficacy of naftopidil and tamsulosin hydrochloride in medical treatment of benign prostatic enlargement
por: Perumal, Chenthil, et al.
Publicado: (2015)

Establishment of Reference Ranges for Prostate Volume and Annual Prostate Volume Change Rate in Korean Adult Men: Analyses of a Nationwide Screening Population
por: Park, Jinsung, et al.
Publicado: (2015)

Impact of Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia Treatment with Tamsulosin and Solifenacin Combination Therapy on Erectile Function
por: Seo, Deok Ha, et al.
Publicado: (2011)

Terazosin Analogs Targeting Pgk1 as Neuroprotective Agents: Design, Synthesis, and Evaluation
por: Wang, Yang, et al.
Publicado: (2022)

Impact of Treatment With Statins on Prostate-Specific Antigen and Prostate Volume in Patients With Benign Prostatic Hyperplasia
por: Lee, Sang Hun, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_n5f5gan0o4g9fe445vvgftagr5